Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- Check6 days agoChange DetectedVersion bump from v3.0.0-post.1-g752effb-HEAD to v3.0.2; no other content changes detected.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated to a new version, v3.0.0-post.1-g752effb-HEAD, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to include a new facility name and a comprehensive list of locations across various countries, while also removing outdated location entries. The total number of study locations has been adjusted from 258 to 257.SummaryDifference19%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check42 days agoChange DetectedThe web page has been updated from version 2.16.8 to version 2.16.11, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check49 days agoChange DetectedThe page has updated its research site information, now listing 258 locations and indicating that the study is currently recruiting, with specific sites in various countries. Additionally, the revision number has been updated to v2.16.8.SummaryDifference2%
Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.